Company: HCTI
Filing Date: 2025-08-01
Form Type: 8-K
Source: 0001213900-25-070705
Chunk: 1

Company: Healthcare Triangle, Inc.
Filing Date: 2025-08-01
Form: 8-K
Item: Item 8.01
Chunk 1
---
Item 8.01. Other Events

On August 1, 2025, Healthcare Triangle, Inc.
(the “ Company”) effected a one-for-two hundred forty-nine (1:249) reverse stock split of all issued and outstanding
shares of the Company’s common stock, par value $0.00001 per share (the “ Common Stock”) effective as of 12:01 a. m.
Eastern Time on August 1, 2025 (the “ Reverse Stock Split”), videa Certificate of Correction (the
“ Certificate of Correction”) to the Certificate of Amendment to the Amended and Restated Certificate of Incorporation of
Healthcare Triangle, Inc (the “ Certificate of Amendment”) filed with the Secretary of State of Delaware, and deemed
effective on August 1, 2025 at 12:01 a. m. Eastern Time. The Reverse Stock Split was intended to bring the Company into compliance
with the $1.00 minimum bid price requirement for continued listing on the NASDAQ Capital Market, as required by Nasdaq Listing Rule
5550(a)(2).

As a result of the Reverse Stock Split, every
two hundred forty-nine (249) shares of issued and outstanding Common Stock combined into one (1) validly issued, fully paid and nonassessable
share of Common Stock. The Reverse Stock Split uniformly affected all issued and outstanding shares of Common Stock and did not alter
any stockholder’s percentage ownership interest in the Company, except to the extent that the Reverse Stock Split resulted in the
fractional interests. No fractional shares were issued in connection with the Reverse Stock Split. Stockholders who otherwise were entitled
to receive fractional shares of Common Stock were automatically entitled to receive an additional fraction of a share of common stock
to round up to the next whole share, at a participant level. Proportional adjustments have also been made to the Company’s
outstanding warrants, stock options, and convertible securities, as well as to the reserves available pursuant to the terms of the Company’s
2020 Equity Incentive Plans to reflect the Reverse Stock Split, in each case, in accordance with the terms thereof.

The Reverse Stock Split reduced the
number of shares of Common Stock issued and outstanding from 1,452,124,283 to 5,831,816 shares of Common Stock. The number of authorized
shares of Common Stock did not change by the Reverse Stock Split.

The Company’s transfer agent, VStock Transfer,
LLC acted as the exchange agent for